{"version":"1.0","provider_name":"Brakke Consulting\u306e\u30a6\u30a7\u30d6\u30b5\u30a4\u30c8","provider_url":"https:\/\/brakkeconsulting.com\/ja","title":"News from Brakke Consulting","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"1wrT19mvnU\"><a href=\"https:\/\/brakkeconsulting.com\/ja\/23515\/\">2001\u5e748\u670817\u65e5\u306e\u52d5\u7269\u5065\u5eb7\u30cb\u30e5\u30fc\u30b9\u3068\u30ce\u30fc\u30c8<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/brakkeconsulting.com\/ja\/23515\/embed\/#?secret=1wrT19mvnU\" width=\"600\" height=\"338\" title=\"&#8220;Animal Health News &#038; Notes for August 17, 2001&#8221; &#8212; Brakke Consulting Website\" data-secret=\"1wrT19mvnU\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script type=\"text\/javascript\">\n\/* <![CDATA[ *\/\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/brakkeconsulting.com\/wp-includes\/js\/wp-embed.min.js\n\/* ]]> *\/\n<\/script>","description":"**************************************************************** Brakke Consulting&rsquo;s Animal Health News &amp; Notes for August 17, 2001 Copyright &copy; Brakke Consulting, Inc. **************************************************************** Company Earnings Releases &gt;&nbsp; Bayer reported that sales for the first half of 2001 for its animal health division were down 6% compared to the comparable period in 2000, of which 5% represented the divestiture of the US livestock vaccines business.&nbsp; Good growth rates were achieved by the flea control product Advantage in North America and Japan, and the anti-infective Baytril in North America. (company website) &gt;&nbsp; Novartis reported that sales for the first half of 2001 for its animal health division were CHF 490 million ($273 million), a decrease of 5% (2% in local currencies) over the first half of 2000.&nbsp; Operating income for the first half of 2001 was CHF 66 million ($37 million), unchanged from the prior year period.&nbsp; Shortfalls in the US, due to the economic slowdown and competitive pressures in the flea treatment segment, and setbacks in the UK due to the foot and mouth outbreak, were largely offset by the performance in Latin America and Asia.&nbsp; Significant sales growth was achieved by Tiamulin and by the recently acquired vaccine businesses.&nbsp; Fortekor also grew strongly.&nbsp; (company website) &gt;&nbsp; IGI, INC. reported $819,000 in operating profit on revenues of $4.1 million for the second quarter ended June 30,View Full Post;"}